Shay Capital LLC Kiromic Biopharma, Inc. Transaction History

Shay Capital LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$1.53 - $3.12 $8,109 - $16,536	5,300 Added 44.17%	17,300 $26,000
Q3 2021 Nov 15, 2021	SELL	$2.69 - $4.94 $34,970 - $64,220	-13,000 Reduced 52.0%	12,000 $37,000
Q2 2021 Aug 13, 2021	BUY	$4.81 - $10.34 $120,249 - $258,500	25,000 New	25,000 $120,000

107K

Ticker KRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,843,200
Market Cap $16M
Description
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Shay Capital LLC with notifications on news.